Upstream Bio (UPB) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for Upstream Bio (UPB) over the last 2 years, with Q3 2025 value amounting to $2.5 million.

  • Upstream Bio's Cost of Revenue rose 1665.9% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year change of. This contributed to the annual value of $6.6 million for FY2024, which is 9507.86% up from last year.
  • Upstream Bio's Cost of Revenue amounted to $2.5 million in Q3 2025, which was up 1665.9% from $10.0 million recorded in Q2 2025.
  • Upstream Bio's Cost of Revenue's 5-year high stood at $10.0 million during Q2 2025, with a 5-year trough of $351000.0 in Q1 2024.